A. von Matt

New pyrazolo[1,5a]pyrimidines as orally active inhibitors of Lck.

P. Furet, B. Pirard, S. Cowan-Jacob, 2010, Bioorganic & medicinal chemistry letters.

Discovery of novel pyrrolidineoxy-substituted heteroaromatics as potent and selective PI3K delta inhibitors with improved physicochemical properties.

R. Wolf, R. Wilcken, F. Zécri, 2016, Bioorganic & medicinal chemistry letters.

Selective boron-containing thrombin inhibitors--X-ray analysis reveals surprising binding mode.

P. Burkhard, C. Ehrhardt, R. Metternich, 2000, Bioorganic & medicinal chemistry.

Identification of orally available naphthyridine protein kinase D inhibitors.

I. Enyedy, T. McKinsey, Margaret R Pancost, 2010, Journal of medicinal chemistry.

Aromatic quinolinecarboxamides as selective, orally active antibody production inhibitors for prevention of acute xenograft rejection.

C. Heusser, K. Wagner, M. Schreier, 2001, Journal of medicinal chemistry.

2,6-Naphthyridines as potent and selective inhibitors of the novel protein kinase C isozymes.

G. Rummel, S. Cowan-Jacob, E. Vangrevelinghe, 2011, Bioorganic & medicinal chemistry letters.

2,6-Naphthyridines as potent and selective inhibitors of the novel protein kinase C isozymes.

G. Rummel, S. Cowan-Jacob, E. Vangrevelinghe, 2011, Bioorganic & medicinal chemistry letters.